Marc Ladanyi

Memorial Sloan Kettering Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

30.8Author DataRank

Indexed papers

10in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 10 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive genomic characterization of squamous cell lung cancers

Nature(2012)10.1038/nature11404

Top 1%

11.0DataRank

Top 1%4036 citations

Gad Getz, Stephen E. Schumacher, Petar Stojanov, Chang‐Jiun Wu, Hailei Zhang +326 more

Papers

Driven by 123 papers — median percentile 96. Top paper: “Comprehensive genomic characterization of squamous cell lung cancers”.

Comprehensive genomic characterization of squamous cell lung cancers

Nature(2012)10.1038/nature11404

Top 1%

11.0DataRank

Top 1%4036 citations

Gad Getz, Stephen E. Schumacher, Petar Stojanov, Chang‐Jiun Wu, Hailei Zhang +326 more

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types

Nature Biotechnology(2021)10.1038/s41587-021-01070-8

N/A

7.3DataRank · unranked

272 citations

Seong‐Keun Yoo, Cristina Valero, Alessandro Pastore, Chirag Krishna, Mark Lee +29 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0467

Top 4%

5.0DataRank

Top 4%401 citations

Moriah H. Nissan, Hongxin Zhang, Ritika Kundra, Subhiksha Nandakumar, Calvin Lu +21 more

Clonal hematopoiesis is associated with risk of severe Covid-19

Nature Communications(2021)10.1038/s41467-021-26138-6

N/A

3.5DataRank · unranked

140 citations

Youngil Koh, Michael B. Foote, Hogune Im, Justin Jee, Choong Hyun Sun +40 more

NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors

Communications Biology(2020)10.1038/s42003-020-01508-w

N/A

2.2DataRank · unranked

63 citations

Nicolle E. Hofmann, Bryan D. Smith, Igor Odintsov, Morana Vojnic, Irina Linkov +10 more

Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting

Nature Communications(2021)10.1038/s41467-021-21613-6

N/A

2.0DataRank · unranked

71 citations

Benjamin P. Brown, Soyeon Kim, Donna C. Ferguson, Dean C. Pavlick, Gowtham Jayakumaran +13 more

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3321

N/A

1.9DataRank · unranked

48 citations

Adam J. Schoenfeld, Evan Siau, Yue Christine Lu, Huichun Tai, Ken Suzawa +17 more

Integrated genomic analyses of ovarian carcinoma

Nature(2011)10.1038/nature10166

N/A

1.3DataRank · unranked

8094 citations

Debra Bell, Andrew Berchuck, Michael J. Birrer, Jeremy Chien, D. W. Cramer +268 more

The landscape of somatic copy-number alteration across human cancers

Nature(2010)10.1038/nature08822

N/A

1.2DataRank · unranked

4101 citations

Craig H. Mermel, Dale A. Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan +61 more

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.09.225

N/A

1.0DataRank · unranked

37 citations

Pang‐Dian Fan, Besnik Qeriqi, Azadeh Namakydoust, Bobby Daly, Linda S. Ahn +9 more

Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis

Bioinformatics(2009)10.1093/bioinformatics/btp543

N/A

1.0DataRank · unranked

884 citations

Adam B. Olshen, Marc Ladanyi, Ronglai Shen

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Nature Genetics(2020)10.1038/s41588-020-00710-0

N/A

0.993DataRank · unranked

750 citations

Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly +59 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.10.004

N/A

0.941DataRank · unranked

34 citations

Erika Gedvilaite, Ryan Ptashkin, Jason C. Chang, John Ziegler, Douglas A. Mata +14 more

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors

Nature Communications(2021)10.1038/s41467-021-20935-9

N/A

0.920DataRank · unranked

459 citations

Mark Lee, Douglas R. Hoen, Kate Weiss, Daniel W. Kelly, Prasad S. Adusumilli +24 more

Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR / KRA S and Presence of PIK3CA / AKT1 Mutations

Clinical Cancer Research(2012)10.1158/1078-0432.ccr-11-2109

N/A

0.885DataRank · unranked

364 citations

Paul K. Paik, Maria E. Arcila, Laura J. Tafe, Geoffrey R. Oxnard, William D. Travis +5 more

The association between tumor mutational burden and prognosis is dependent on treatment context

Nature Genetics(2021)10.1038/s41588-020-00752-4

N/A

0.836DataRank · unranked

263 citations

Mark Lee, Douglas R. Hoen, Jingming Wang, Zaineb Nadeem, Neal Patel +22 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0.808DataRank · unranked

218 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0.792DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5

N/A

0.782DataRank · unranked

183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

EWS-FLI1 and EWS-ERG Gene Fusions Are Associated With Similar Clinical Phenotypes in Ewing's Sarcoma

Journal of Clinical Oncology(1999)10.1200/jco.1999.17.6.1809

N/A

0.778DataRank · unranked

178 citations

Enrique de Alava, Marc Ladanyi, Leonard H. Wexler, Heinrich Kovar, Michael Paulussen +10 more

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1119

N/A

0.770DataRank · unranked

169 citations

Igor Odintsov, Madelyn Espinosa-Cotton, Inna Khodos, Whitney J. Sisso, Marissa S. Mattar +17 more

Treatment Outcomes and Clinical Characteristics of Patients with KRAS-G12C–Mutant Non–Small Cell Lung Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4023

N/A

0.725DataRank · unranked

125 citations

Hira Rizvi, Andrew J. Plodkowski, Matthew D. Hellmann, Andrea Knežević, Glenn Heller +8 more

Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2278

N/A

0.724DataRank · unranked

124 citations

Melissa L. Johnson, Sarah Clifford, Romel Somwar, Jennifer Kherani, Jieun Son +23 more

Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0423

N/A

0.700DataRank · unranked

105 citations

Michael Offin, Christina J. Falcon, David N. Brown, Brian Houck‐Loomis, Fanli Meng +21 more

Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.022

N/A

0.695DataRank · unranked

102 citations

Antonio Marra, Jane Sze Yin Sui, Jessica Flynn, Soo‐Ryum Yang, Christina J. Falcon +14 more

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Genome Medicine(2021)10.1186/s13073-021-00898-8

N/A

0.614DataRank · unranked

59 citations

Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won +32 more

Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing

Annals of Oncology(2022)10.1016/j.annonc.2022.01.006

N/A

0.604DataRank · unranked

55 citations

Fresia Pareja, David N. Brown, Ozge Ceyhan‐Birsoy, Maksym Misyura, Satshil Rana +16 more

The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3605

N/A

0.593DataRank · unranked

51 citations

Allan J.W. Lui, Whitney J. Sisso, Eric Gladstone, Zebing Liu, Lukas Delasos +10 more

RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors

Urology(2020)10.1016/j.urology.2020.07.027

N/A

0.591DataRank · unranked

13 citations

Soo‐Ryum Yang, Donna C. Ferguson, Ying Liu, Rohit Sharma, Jamal Benhamida +11 more

Chromothripsis-Mediated Small Cell Lung Carcinoma

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0286

N/A

0.584DataRank · unranked

48 citations

Sam E. Tischfield, Christopher A. Febres‐Aldana, Jake June-Koo Lee, Jason C. Chang, Benjamin Herzberg +37 more

DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma

PLoS ONE(2013)10.1371/journal.pone.0079526

N/A

0.568DataRank · unranked

43 citations

Ming Chen, Alessandro Morotti, Justyna A. Janas, Masaru Niki, Roderick T. Bronson +7 more

Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response

Modern Pathology(2023)10.1016/j.modpat.2023.100165

N/A

0.564DataRank · unranked

42 citations

Walid K. Chatila, Cecilia Lezcano, Christopher A. Febres‐Aldana, Nikolaus Schultz, Chad Vanderbilt +10 more

The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective study

The Lancet Digital Health(2021)10.1016/s2589-7500(21)00104-7

N/A

0.564DataRank · unranked

42 citations

Axel Martin, Jacklynn V. Egger, Hira Rizvi, Michael Offin, Andreas Rimner +7 more

Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100077

N/A

0.557DataRank · unranked

40 citations

Soo‐Ryum Yang, Amir Momeni, Douglas A. Mata, Paulo Salazar, Roger Chan +9 more

Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.03.023

N/A

0.557DataRank · unranked

40 citations

Jason C. Chang, Charles Leduc, Kay See Tan, Snjezana Doğan, Ryma Benayed +8 more

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

Nature Cancer(2023)10.1038/s43018-023-00630-y

N/A

0.553DataRank · unranked

39 citations

Igor Odintsov, Keiji Ishida, Allan J.W. Lui, Masanori Kato, Tatsuya Suzuki +28 more

Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.01488

N/A

0.542DataRank · unranked

36 citations

Meagan Montesion, Smruthy Sivakumar, Caryn Hale, Anita S. Bowman, Ayyüce Begüm Bektaş +29 more

Cancer-Causative Mutations Occurring in Early Embryogenesis

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1110

N/A

0.542DataRank · unranked

36 citations

Ryan Ptashkin, David N. Brown, Fatemeh Derakhshan, Pier Selenica, Edaise M. da Silva +31 more

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1207

N/A

0.542DataRank · unranked

36 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Hira Rizvi, Arielle Elkrief +23 more

Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma

Ophthalmology Science(2021)10.1016/j.xops.2021.100015

N/A

0.529DataRank · unranked

33 citations

Diana Mandelker, Jasmine H. Francis, Ira J. Dunkel, A. Rose Brannon, Ryma Benayed +13 more

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1287

N/A

0.524DataRank · unranked

32 citations

Chaitanya Bandlamudi, Matthew D. Hellmann, Yelena Kemel, Esther Drill, Hira Rizvi +32 more

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.03.013

N/A

0.524DataRank · unranked

32 citations

Marissa S. Mattar, Allan J.W. Lui, Michael Offin, Christopher Kurzatkowski, Lukas Delasos +9 more

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

UNC Libraries(2020)10.17615/s7re-zq82

N/A

0.520DataRank · unranked

31 citations

Marc Ladanyi, William Lee, David G. Beer, Bryan Hernandez, David J. Kwiatkowski +27 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

Nature Communications(2023)10.1038/s41467-023-42585-9

N/A

0.510DataRank · unranked

29 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Rapid EGFR Mutation Detection Using the Idylla Platform

Journal of Molecular Diagnostics(2020)10.1016/j.jmoldx.2020.11.009

N/A

0.500DataRank · unranked

27 citations

Paulo Salazar, Tao Zheng, Nana Yaa Mensah, Ivelise Rijo, Snjezana Doğan +11 more

The molecular pathology of cancer: from pan‐genomics to post‐genomics

The Journal of Pathology(2018)10.1002/path.5057

N/A

0.500DataRank · unranked

27 citations

Marc Ladanyi, David G Huntsman

Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.12.019

N/A

0.489DataRank · unranked

25 citations

Maisam Makarem, Mizuki Nishino, S. Emily Bachert, Tom Zhang, Jaclyn LoPiccolo +11 more

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

Cancer Cell(2025)10.1016/j.ccell.2025.11.002

N/A

0.477DataRank · unranked

23 citations

Daniel Schrimpf, Areeba Patel, Dominik Sturm, Natalie Jäger, Philipp Sievers +95 more

Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3981

N/A

0.472DataRank · unranked

12 citations

Soo‐Ryum Yang, Jessica J. Tao, Antoine Desîlets, Eli L. Diamond, Clare Wilhelm +18 more

Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01846-4

N/A

0.457DataRank · unranked

20 citations

Alexandra Miller, Bridget M Holle, Justin Jee, Siyang Liu, Dara S. Ross +27 more

Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer

Cell(2024)10.1016/j.cell.2024.11.010

N/A

0.449DataRank · unranked

19 citations

Maria Perry, Samuel I. Gould, Arielle Elkrief, Anton Safonov, Rohit Thummalapalli +23 more

Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma

Modern Pathology(2024)10.1016/j.modpat.2023.100420

N/A

0.442DataRank · unranked

18 citations

Jason C. Chang, Achim A. Jungbluth, Prasad S. Adusumilli, Francis M. Bodd, Denise Frosina +13 more

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006994

N/A

0.416DataRank · unranked

15 citations

Joao V. Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R. Preeshagul +16 more

Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions

Histopathology(2024)10.1111/his.15380

N/A

0.403DataRank · unranked

6 citations

Nora Katabi, Purvil Sukhadia, Kerry Mullaney, Michael Zaidinski, Jennifer R. Cracchiolo +7 more

Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100256

N/A

0.396DataRank · unranked

13 citations

Eusebio Manchado, Matthew J. Bott, Linda S. Ahn, Yosef Y. Tobi, Andy Ai Ni +14 more

RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation

Disease Models & Mechanisms(2020)10.1242/dmm.047779

N/A

0.385DataRank · unranked

12 citations

Igor Odintsov, Roger S. Smith, Kota Ishizawa, Allan J. W. Liu, Lukas Delasos +17 more

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer

The Oncologist(2023)10.1093/oncolo/oyad197

N/A

0.385DataRank · unranked

12 citations

Biagio Ricciuti, Joao V. Alessi, Teng Fei, Hannah L. Kalvin, Jacklynn V. Egger +16 more

MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1 -Fusion-Positive Lung Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0025

N/A

0.373DataRank · unranked

11 citations

Igor Odintsov, Adam J. Schoenfeld, Evan Siau, Marissa S. Mattar, Elisa de Stanchina +7 more

Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings

Haematologica(2024)10.3324/haematol.2024.285055

N/A

0.360DataRank · unranked

10 citations

Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer A. Kennedy, Zarina Yelskaya +40 more

Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies

Haematologica(2024)10.3324/haematol.2024.285054

N/A

0.345DataRank · unranked

9 citations

Kseniya Petrova‐Drus, Ryan Ptashkin, Mark D. Ewalt, JinJuan Yao, Ying Liu +43 more

Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2024

N/A

0.330DataRank · unranked

8 citations

Allan J.W. Lui, Kota Ishizawa, Isao Miyazaki, Inna Khodos, Kentaro Wakayama +11 more

Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0085

N/A

0.312DataRank · unranked

7 citations

Gowtham Jayakumaran, Jamal Benhamida, Christopher A. Febres Aldana, Rachel Fanaroff, Jason C. Chang +7 more

Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library

Genome Medicine(2022)10.1186/s13073-022-01129-4

Top 55%

0.296DataRank

Top 55%5 citations

Jennifer L. Sauter, Sam E. Tischfield, Jacklynn V. Egger, Shweta S. Chavan, Nisargbhai Shah +14 more

CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma

Cancer Research(2022)10.1158/0008-5472.can-21-1397

N/A

0.292DataRank · unranked

6 citations

Michael V. Ortiz, Inna Khodos, Marissa S. Mattar, Allan J.W. Lui, Shinji Kohsaka +5 more

Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling

Nature Communications(2025)10.1038/s41467-024-55456-8

N/A

0.269DataRank · unranked

5 citations

Chad Vanderbilt, Soo‐Ryum Yang, Subhiksha Nandakumar, Khédoudja Nafa, Rusmir Feratovic +10 more

Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.010

N/A

0.269DataRank · unranked

5 citations

Rohit Thummalapalli, Christopher A. Febres‐Aldana, Daniel M. Muldoon, Christina J. Falcon, Amanda Pupo +18 more

Genomic landscape of MTAP deletions and association with EGFR alterations in NSCLC.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.8599

N/A

0.208DataRank · unranked

3 citations

Daniel M. Muldoon, Christopher A. Febres‐Aldana, Christina J. Falcon, Amanda Pupo, Chaitanya Bandlamudi +6 more

Genomic characterization of tumor mutational burden-high breast carcinomas

npj Precision Oncology(2025)10.1038/s41698-025-01045-x

N/A

0.208DataRank · unranked

3 citations

Chad Vanderbilt, Satshil Rana, Abhinita Mohanty, Fresia Pareja, Edi Brogi +6 more

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR -Mutant Lung Adenocarcinomas

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3484

N/A

0.165DataRank · unranked

2 citations

Alex Makhnin, Khadeja A. Moses, Linda S. Ahn, Isabel R. Preeshagul, Afsheen N. Iqbal +9 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

medRxiv(2022)10.1101/2022.10.03.22280675

N/A

0.130DataRank · unranked

1 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Improving Global Access to Genomic Profiling in Rare Pediatric Cancers

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3910

N/A

0.104DataRank · unranked

1 citations

Tara J. O’Donohue, Tejus Bale, Anita S. Bowman, Katherine E. Hill, Emily Stockfisch +20 more

DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas

Modern Pathology(2023)10.1016/j.modpat.2023.100321

N/A

0DataRank · unranked

8 citations

Douglas H. R. Allison, Gulisa Turashvili, Varshini Vasudevaraja, Ivy Tran, Jonathan Serrano +6 more

Data from Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report

(2023)10.1158/1078-0432.c.6519293.v1

N/A

0DataRank · unranked

0 citations

Emil Lou, Christopher G. Azzoli, Rekha Reddy, Mark E. Robson, Megan Harlan +12 more

Data from Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma

(2023)10.1158/0008-5472.c.6499367.v1

N/A

0DataRank · unranked

0 citations

Qingrong Chen, Lei Zhang, Amanda T. McCleish, A. Y. Rodriguez, Min Jung Cho +15 more

Data from CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma

(2023)10.1158/0008-5472.c.6513894.v1

N/A

0DataRank · unranked

0 citations

Michael V. Ortiz, Inna Khodos, Marissa S. Mattar, Allan J.W. Lui, Shinji Kohsaka +5 more

Data from Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

(2023)10.1158/1078-0432.c.6520155

N/A

0DataRank · unranked

0 citations

Paul K. Paik, Maria E. Arcila, Laura J. Tafe, Geoffrey R. Oxnard, André L. Moreira +5 more

Data from Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases

(2023)10.1158/1078-0432.c.6518830.v1

Top 100%

0DataRank

Top 100%0 citations

Mary Jo Fackler, Marc K. Halushka, Diana Weedman Molavi, M. Evangeline Taylor, Wei Wen Teo +10 more

Data from Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes

(2023)10.1158/1078-0432.c.6530487.v1

N/A

0DataRank · unranked

0 citations

Michael Offin, Christina J. Falcon, David N. Brown, Brian Houck‐Loomis, Fanli Meng +21 more

Data from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

(2023)10.1158/1078-0432.c.6532878.v1

N/A

0DataRank · unranked

0 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Data from Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report

(2023)10.1158/1078-0432.c.6519293

N/A

0DataRank · unranked

0 citations

Emil Lou, Christopher G. Azzoli, Rekha Reddy, Mark E. Robson, Megan Harlan +12 more

POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10511

N/A

0DataRank · unranked

0 citations

Semanti Mukherjee, Ming Gao, Elise Fiala, Audrey Mauguen, Yelena Kemel +14 more

Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1559

N/A

0DataRank · unranked

0 citations

Andrew Schroeder, Subrata Chatterjee, John Cadley, Christina J. Falcon, Miika Mehine +15 more

Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9107

N/A

0DataRank · unranked

0 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Jia Luo, Joao Victor Machado Alessi +13 more

Overcoming Clinical Resistance to EZH2 Inhibition Using Rational Epigenetic Combination Therapy

Cancer Discovery(2024)10.1158/2159-8290.cd-23-0110

N/A

0DataRank · unranked

45 citations

Daniel Cameron, Helen S. Mueller, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti +11 more

Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations

Journal of Molecular Diagnostics(2022)10.1016/j.jmoldx.2022.03.006

N/A

0DataRank · unranked

17 citations

Jada Barbee, Soo‐Ryum Yang, Jason C. Chang, Priscilla Liang, Kerry Mullaney +9 more

Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100852

N/A

0DataRank · unranked

36 citations

Claire F. Friedman, Jennifer J. Mueller, Ryma Benayed, Marc Ladanyi, Maria E. Arcila +4 more

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing

European Urology Oncology(2021)10.1016/j.euo.2021.09.005

N/A

0DataRank · unranked

39 citations

Rania Sheikh, Ritesh R. Kotecha, Yelena Kemel, Peter A. Reisz, Andrew T. Lenis +22 more

HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1835

N/A

0DataRank · unranked

19 citations

Christopher A. Febres‐Aldana, Zebing Liu, Jenna-Marie Dix, Ryan Cheng, Raymond G. Dematteo +13 more

Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer

Nature Communications(2021)10.1038/s41467-021-24841-y

N/A

0DataRank · unranked

49 citations

Amanda K. Riley, Naomi T. Nkinsi, Shriya Kamlapurkar, Phoebe C. R. Parrish, April Lo +16 more

Molecular Characterization of Peritoneal Mesotheliomas

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.09.012

N/A

0DataRank · unranked

51 citations

Soo‐Ryum Yang, Jacklynn V. Egger, Gowtham Jayakumaran, Rowanne S Spencer, Jessica Lopardo +8 more

Immuno-transcriptomic profiling of extracranial pediatric solid malignancies

Cell Reports(2021)10.1016/j.celrep.2021.110047

N/A

0DataRank · unranked

74 citations

Sivasish Sindiri, Jun S. Wei, David Milewski, Hsien-Chao Chou, Young C. Song +32 more

Clinicopathologic and Genomic Analysis of TP53 -Mutated Endometrial Carcinomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4436

N/A

0DataRank · unranked

107 citations

Wissam Dahoud, Chad Vanderbilt, Sarah Chiang, Rajmohan Murali, Eric Rios‐Doria +8 more

Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors

Annals of Surgical Oncology(2024)10.1245/s10434-024-16004-2

N/A

0DataRank · unranked

6 citations

Nicole Aguirre, Soo Ryum Yang, Jennifer L. Sauter, Georgios Karagkounis, Mostafa Mohamed +9 more

Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling – A report on the impact of process optimization through the analysis of 4,871 cytology samples profiled by MSK-IMPACT

Research Square(2024)10.21203/rs.3.rs-4746484/v1

N/A

0DataRank · unranked

0 citations

Chad Vanderbilt, Soo‐Ryum Yang, Subhiksha Nandakumar, Khédoudja Nafa, Rusmir Feratovic +10 more

Clonal hematopoiesis is associated with risk of severe Covid-19

medRxiv(2020)10.1101/2020.11.25.20233163

N/A

0DataRank · unranked

29 citations

Youngil Koh, Michael B. Foote, Hogune Im, Justin Jee, Choong Hyun Sun +38 more

Correlation of Histologic Features with Gene Alterations in Pleural Mesothelioma

Modern Pathology(2025)10.1016/j.modpat.2025.100706

N/A

0DataRank · unranked

6 citations

Soo‐Ryum Yang, Kay See Tan, Prasad S. Adusumilli, Francis M. Bodd, Anita S. Bowman +10 more

Leveraging RNA from DNA Extraction Lysate to Rescue “Insufficient” Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor Specimens

Journal of Molecular Diagnostics(2025)10.1016/j.jmoldx.2025.04.005

N/A

0DataRank · unranked

0 citations

Sara DiNapoli, Kerry Mullaney, Alison M. Urvalek, Minji K. Uh, Purvil Sukhadia +14 more

RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.19.677259

N/A

0DataRank · unranked

0 citations

Tom Zhang, Ryan R. Cheng, Marissa S. Mattar, Juan Luis Gomez Marti, Leo Gili +12 more

Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients

Annals of Oncology(2020)10.1016/j.annonc.2020.04.008

N/A

0DataRank · unranked

33 citations

Bo Liu, Alison M. Schram, Pedram Razavi, Stephen M. Lagana, Y. Zhang +10 more

Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung Cancers

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.09.019

N/A

0DataRank · unranked

19 citations

Michael Offin, Daisuke Kubota, Helena A. Yu, Clare Wilhelm, Shinichi Toyooka +4 more

Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling

Disease Models & Mechanisms(2021)10.1242/dmm.047621

N/A

0DataRank · unranked

33 citations

Igor Odintsov, Zebing Liu, Allan J.W. Lui, Takuo Hayashi, Morana Vojnic +22 more

A novel case of cutaneous myxoid spindle cell neoplasm with FMR1‐ALK gene fusion and CD34/S100 co‐expression

Journal of Cutaneous Pathology(2022)10.1111/cup.14354

N/A

0DataRank · unranked

9 citations

Umut Aypar, Purvil Sukhadia, Chad Vanderbilt, Marc Ladanyi, Tierra Hurd +2 more

Dual NF2-YAP/TAZ immunohistochemistry is a reliable marker for the detection of NF2 alterations in diffuse pleural mesothelioma

Research Square(2022)10.21203/rs.3.rs-1720495/v1

N/A

0DataRank · unranked

0 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

Research Square(2022)10.21203/rs.3.rs-2094202/v1

N/A

0DataRank · unranked

0 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Efficacy of PD-(L)1 blockade monotherapy compared to PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

medRxiv(2022)10.1101/2022.12.05.22283131

N/A

0DataRank · unranked

0 citations

Joao M. Victor Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R. Preeshagul +16 more

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1663

N/A

0DataRank · unranked

28 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma

Journal of Clinical Oncology(2023)10.1200/jco.23.00561

N/A

0DataRank · unranked

44 citations

Antonio Marra, Binbin Zheng-Lin, Pier Selenica, Juan Blanco-Heredia, Yingjie Zhu +30 more

Defining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor/Normal Matched Sequencing Data

Journal of Molecular Diagnostics(2022)10.1016/j.jmoldx.2022.01.011

N/A

0DataRank · unranked

33 citations

Anita S. Bowman, Sumit Middha, Kseniya Petrova‐Drus, Yi‐Wei Tang, Xin Chen +12 more

Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

Genome Medicine(2022)10.1186/s13073-022-01101-2

N/A

0DataRank · unranked

45 citations

Gowtham Jayakumaran, Yelena Kemel, Maksym Misyura, Umut Aypar, Sowmya Jairam +20 more

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

Nature Communications(2022)10.1038/s41467-022-28848-x

N/A

0DataRank · unranked

114 citations

Helen Won, Youyun Zheng, Emiliano Cocco, Duygu Selcuklu, Yixiao Gong +27 more

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Nature Communications(2022)10.1038/s41467-022-30496-0

N/A

0DataRank · unranked

194 citations

Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis +38 more

Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue Sarcomas

Sarcoma(2021)10.1155/2021/5575444

N/A

0DataRank · unranked

3 citations

Arielle Elkrief, Wei Guo, Neerav Shukla, Mrinal M. Gounder, Marc Ladanyi +1 more

Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.05.007

N/A

0DataRank · unranked

20 citations

Igor Odintsov, Vladimir Markov, Rebecca Caeser, Paweł Sobczuk, Sam E. Tischfield +14 more

Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab117

N/A

0DataRank · unranked

19 citations

Pier Selenica, M. Herman Chui, Gowtham Jayakumaran, Ryan Ptashkin, Maksym Misyura +20 more

MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0218

N/A

0DataRank · unranked

11 citations

Logan C. Tyler, Anh T. Le, Eric A. Welsh, Bin Fang, Andrew Elliott +7 more

Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0627

N/A

0DataRank · unranked

8 citations

Jonathan Serrano, Guomiao Shen, Ivy Tran, Cheyanne C. Slocum, Courtney Ketchum +23 more

Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma

Modern Pathology(2023)10.1016/j.modpat.2022.100030

N/A

0DataRank · unranked

13 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Marc Ladanyi

Indexed papers

Top data-sharing exemplar

Papers